chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain
Clinical narrative: tenderness in area of injection; noted blotchy redness, no pain, extending  6 in below shot site; This is a spontaneous report from a contactable consumer who reported for herself. A 74-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Lot number: EL 9263) via an unspecified route of administration on 29Jan2021 at 19:30 (at the age of 74-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included HTN (hypertension), atherosclerosis, hip replacement, TIA (transient ischemic attack) and "INCR" lipids (increased lipids), all from unspecified dates and unspecified if ongoing. The patient had no known allergies to mediations, food or other products. Concomitant medications (received within 2 weeks of vaccination) included nebivolol hydrochloride (BYSTOLIC), lisinopril, calcium citrate (CITRACAL), ezetimibe (ZETIA) and pitavastatin calcium (LIVALO), all taken for unspecified indications on unspecified dates. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient experienced tenderness in area of injection and noted blotchy redness, no pain, extending 6 in below shot site, both on 29Jan2021 at 23:00, both reported as non-serious. The events did not cause hospitalization. The clinical course was reported as follows: "tenderness in area of injection began hours after injection and increased over 24hrs and began to decease. 52hrs p shot noted blotchy redness, no pain, extending 6 in below shot site. Still there 18hrs later but fading in color." No treatment was received for the events. It was reported that it was unknown whether the patient was recovered. The clinical outcomes of the events tenderness in area of injection and noted blotchy redness, no pain, extending 6 in below shot site were both unknown.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Hot flush, Illness, Malaise, Musculoskeletal stiffness
Clinical narrative: neck pain (base of skull); neck stiffness; nausea; hot flashes; general fatigue; feeling unwell; sick; This is a spontaneous report from a non-contactable consumer (patient). A 22-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at time of vaccination. The patient was previously vaccinated with first dose of  BNT162B2 on unspecified date at single use for COVID-19 immunization. The patient experienced neck pain (base of skull) / neck stiffness, nausea, hot flashes, general fatigue, feeling "unwell" and was sick on an unspecified date. The outcome of the events was recovered on unspecified date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The events were considered non serious as it did not result in death, was not life threatening, did not cause/prolonged hospitalization, were not disabling/Incapacitating and were not a congenital anomaly/birth defect.  No follow-up attempts are possible. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Neck pain
Clinical narrative: neck pain (base of skull); neck stiffness; nausea; hot flashes; general fatigue; feeling unwell; sick; This is a spontaneous report from a non-contactable consumer (patient). A 22-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at time of vaccination. The patient was previously vaccinated with first dose of  BNT162B2 on unspecified date at single use for COVID-19 immunization. The patient experienced neck pain (base of skull) / neck stiffness, nausea, hot flashes, general fatigue, feeling "unwell" and was sick on an unspecified date. The outcome of the events was recovered on unspecified date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The events were considered non serious as it did not result in death, was not life threatening, did not cause/prolonged hospitalization, were not disabling/Incapacitating and were not a congenital anomaly/birth defect.  No follow-up attempts are possible. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Flushing, Heart rate, Heart rate increased, Throat tightness
Clinical narrative: heart rate suddenly increased; throat felt tight; felt very warm in the head and neck like was flushed; felt very warm in the head and neck like was flushed; This is a spontaneous report from a contactable other healthcare professional (HCP) (patient). A 41-year-old female patient received the first dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot EL9265) via an unspecified route of administration in the left arm on 30Jan2021 10:30 am at a single dose as Covid vaccine. Medical history included known allergies to penicillin- anaphylaxis. There were no concomitant medications (no other vaccine in four weeks and no other medications in two weeks). Approximately 5 minutes after injection, heart rate suddenly increased and throat felt tight, and felt very warm in the head and neck like was flushed on 30Jan2021 10:45 am. It passed after a minute or two, then happened again around five times within the hour after injection. No treatment was provided for the events. The patient had no Covid prior to vaccination and has not had Covid tested positive post vaccination. The outcome of the events was recovered on Jan2021.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Anosmia, Arthralgia, Dysgeusia, Ear pain, Fatigue
Clinical narrative: Blurry Vision; Headaches; Left ear pain; Loss of taste, smell; Loss of taste, smell; Insomnia; Fatigue; Joint pain; Neck pain; This is a spontaneous report from a contactable consumer reporting for himself. A 51-year-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) lot number and expiration date not provided, via an unspecified route of administration on 23Dec2020 at a single dose for COVID-19 immunisation. Medical history included allergies to penicillin and COVID-19 prior to vaccination. Historical vaccine included first dose of BNT162B2 on an unspecified date for COVID-19 immunization. Concomitant medication included unspecified drug. On 09Jan2021, the patient experienced blurry vision, headaches, left ear pain, loss of taste and smell, insomnia, fatigue, joint pain and neck pain. The patient received meloxicam as treatment medication. The events were considered as non-serious. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Insomnia, Neck pain, Vision blurred
Clinical narrative: Blurry Vision; Headaches; Left ear pain; Loss of taste, smell; Loss of taste, smell; Insomnia; Fatigue; Joint pain; Neck pain; This is a spontaneous report from a contactable consumer reporting for himself. A 51-year-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) lot number and expiration date not provided, via an unspecified route of administration on 23Dec2020 at a single dose for COVID-19 immunisation. Medical history included allergies to penicillin and COVID-19 prior to vaccination. Historical vaccine included first dose of BNT162B2 on an unspecified date for COVID-19 immunization. Concomitant medication included unspecified drug. On 09Jan2021, the patient experienced blurry vision, headaches, left ear pain, loss of taste and smell, insomnia, fatigue, joint pain and neck pain. The patient received meloxicam as treatment medication. The events were considered as non-serious. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Chills, Headache, Pyrexia
Clinical narrative: slight swelling; arm redness at injection site; chills; fever 103.8; weakness; headache; This is a spontaneous report from a contactable other health professional (patient). A 58-year-old female non-pregnant patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) lot number EL9262 and expiry date unknown, via unspecified route of administration at the left arm on 28Jan2021 11:15 at single dose for Covid-19 immunization in a hospital. Medical history included high blood pressure, depression, asthma, wheat allergies. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medication included lisinopril, paroxetine hydrochloride (PAXIL [PAROXETINE HYDROCHLORIDE]), cyanocobalamin (VIT B12), ergocalciferol (VIT D); all from unspecified date for unspecified indication. The patient previously took amoxicilin, morphine, vicodin; all experienced drug allergy. Historical vaccine included first dose of BNT162B2 lot number EH9899 at the left arm on 07Jan2021 11:15 AM for covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 28Jan2021 19:00, the patient experienced chills, fever 103.8 (temperature), weakness, headache, until 30Jan2021 6:30 am. Then again, on 30Jan2021 11 pm, the patient experienced fever, chills headache until 6:30 am. On 30Jan2021, the patient experienced arm redness at injection site. On 31Jan2021, the patient continued to experience redness and slight swelling (injection site). The patient has the patient been tested for COVID-19 since the vaccination. The patient did not received treatment for the events. The outcome of the events was recovering. The reporter considered the events non-serious; did not results in death, was not life threatening, did not cause/prolong hospitalization, was not disabling/incapacitating, and no congenital anomaly/birth defect.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling
Clinical narrative: slight swelling; arm redness at injection site; chills; fever 103.8; weakness; headache; This is a spontaneous report from a contactable other health professional (patient). A 58-year-old female non-pregnant patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) lot number EL9262 and expiry date unknown, via unspecified route of administration at the left arm on 28Jan2021 11:15 at single dose for Covid-19 immunization in a hospital. Medical history included high blood pressure, depression, asthma, wheat allergies. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medication included lisinopril, paroxetine hydrochloride (PAXIL [PAROXETINE HYDROCHLORIDE]), cyanocobalamin (VIT B12), ergocalciferol (VIT D); all from unspecified date for unspecified indication. The patient previously took amoxicilin, morphine, vicodin; all experienced drug allergy. Historical vaccine included first dose of BNT162B2 lot number EH9899 at the left arm on 07Jan2021 11:15 AM for covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 28Jan2021 19:00, the patient experienced chills, fever 103.8 (temperature), weakness, headache, until 30Jan2021 6:30 am. Then again, on 30Jan2021 11 pm, the patient experienced fever, chills headache until 6:30 am. On 30Jan2021, the patient experienced arm redness at injection site. On 31Jan2021, the patient continued to experience redness and slight swelling (injection site). The patient has the patient been tested for COVID-19 since the vaccination. The patient did not received treatment for the events. The outcome of the events was recovering. The reporter considered the events non-serious; did not results in death, was not life threatening, did not cause/prolong hospitalization, was not disabling/incapacitating, and no congenital anomaly/birth defect.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: Covid test with nasal swab last week and it came back positive; Covid test with nasal swab last week and it came back positive; This is a spontaneous report from a contactable consumer (husband). A 67-year-old female patient (wife) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration in the right arm on 09Jan2021 at a single dose as Covid-19 vaccine. There were no medical history and no concomitant medications. The reporter called and stated that he and his wife received the first dose of the Pfizer-BioNtech Covid-19 vaccine 3 weeks ago on 09Jan2021, they were ready to receive the second dose of the vaccine; however, last week his wife took a nose swab test and she was positive for Covid-19 on Jan2021. The patient did not visit physician office/emergency room. She felt fine. They would like to know if they could receive the second dose or if they should wait. They had the first shot (Covid-19 Vaccine by Pfizer) he and his wife, and they have an adult child living with them, he didn't qualify because of the age. Their 3 weeks were up and they had been notified to get the second shot, he and his wife, now in between she took a Covid test with nasal swab last week and it came back positive, could they still take it, the second shot? And then what were the chances with them having the first shot, was why she tested positive? No treatment was received for the events. The outcome of the events was unknown.  Information on the lot/ batch number has been requested.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Nausea, Pyrexia, Vomiting
Clinical narrative: Fever; Migraine; Nausea; Throwing up; This is a spontaneous report from a contactable healthcare professional (patient). A 32-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, lot: EL3247), intramuscular on the left arm (at the age of 32years) on 27Jan2021 at 14:00 at single dose for covid-19 immunisation. The patient was not pregnant at the time of vaccination. Medical history included migraines, kidney stones and high cholesterol. The patient had no allergies to medications, food, or other products. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not tested for COVID-19. The reported adverse events were fever, migraine, nausea, and throwing up on 31Jan2021 with no treatment received on all events. The patient considered the events as non-serious. Did not results in death, non- life threatening, did not cause/prolong hospitalization, non-disabling/incapacitating and no congenital anomaly/birth defect. The outcome of the events was unknown.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Nausea, Pain in extremity
Clinical narrative: light headed; slight headache; tired; Upper arm became sore and a bit swollen/Upper arm more swollen and  sore.; Upper arm became sore and a bit swollen/Upper arm more swollen and  sore.; Did not sleep well overnight (always do) and woke up very tired; sick to stomach; This is a spontaneous report from a contactable consumer (patient). A 74-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EL3248, expiry date not reported), via an unspecified route of administration in the left arm on 30Jan2021 15:00 at single dose for COVID-19 immunization. Medical history included Raynaud's phenomenon. Concomitant medications were not reported. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was vaccinated at a hospital. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. The patient previously received fluvastatin sodium (LESCOL) and experienced drug hypersensitivity, and nifedipine (ADALAT) and experienced drug hypersensitivity. On 30Jan2021 17:30, in the evening the patient became light headed, had a slight headache and was tired. Her upper arm became sore and a bit swollen. She did not sleep well overnight (always do) and woke up very tired, sick to stomach. Her upper arm was more swollen and sore. No therapeutic measures was taken as a result of the events. Clinical outcome of the events was recovering.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Poor quality sleep
Clinical narrative: light headed; slight headache; tired; Upper arm became sore and a bit swollen/Upper arm more swollen and  sore.; Upper arm became sore and a bit swollen/Upper arm more swollen and  sore.; Did not sleep well overnight (always do) and woke up very tired; sick to stomach; This is a spontaneous report from a contactable consumer (patient). A 74-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EL3248, expiry date not reported), via an unspecified route of administration in the left arm on 30Jan2021 15:00 at single dose for COVID-19 immunization. Medical history included Raynaud's phenomenon. Concomitant medications were not reported. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was vaccinated at a hospital. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. The patient previously received fluvastatin sodium (LESCOL) and experienced drug hypersensitivity, and nifedipine (ADALAT) and experienced drug hypersensitivity. On 30Jan2021 17:30, in the evening the patient became light headed, had a slight headache and was tired. Her upper arm became sore and a bit swollen. She did not sleep well overnight (always do) and woke up very tired, sick to stomach. Her upper arm was more swollen and sore. No therapeutic measures was taken as a result of the events. Clinical outcome of the events was recovering.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Nausea, Pyrexia, Vaccination site pain
Clinical narrative: Injection site pain; Chills; nausea; fever 99.5; This is a spontaneous report from a contactable consumer.  A 50-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on the right arm on 30Jan2021 10:00 at a single dose for COVID-19 immunization in a clinic. Medical history included high blood pressure and COVID-19 prior to vaccination.  The patient was not pregnant. Concomitant medication included hydrochlorothiazide, lisinopril hydrochlorthiazid, loratadine, and fluticasone propionate (FLONASE). The patient experienced injection site pain, chills, nausea, fever 99.5 on 30Jan2021 10:00. The patient did not receive any treatment for the events. The patient was recovering from the events.  Information on lot/ batch number has been requested.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Chills, Headache, Malaise
Clinical narrative: general feeling of unwellness; chill; headache; loss of balance; This is a spontaneous report from a contactable consumer (reported for himself). An 83-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, lot EL9262, expiry date not reported), via an unspecified route of administration on 26Jan2021 10:30 at a single dose in the left arm for Covid-19 immunization. The patient's medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had no allergies to medications, food, or other products. Concomitant medications included quinapril at 5 mg, cyanocobalamin (B-12) at 2500 ug (2500 mcg), and atorvastatin at 40 mg. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 27Jan2021 08:00 pm, patient experienced a general feeling of unwellness, chill, headache, and loss of balance. The events were reported as not serious (did not result in death, not life-threatening, did not cause/prolonged hospitalization, not disabling/incapacitating and not a congenital anomaly/birth defect). Since the vaccination, the patient had not been tested for COVID-19. No treatment received for the adverse events. The events recovered on an unspecified date in 2021.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Motion sickness, Nausea
Clinical narrative: Uncontrollable chills; stabbing pain all over; headaches; body shakes; nausea; sensitivity to smells; motion; tired; This is a spontaneous report from a contactable healthcare professional. A 54-year-old female patient received the second dose of BNT162B2 (Pfizer-BIONTECH COVID-19 Vaccine; Lot number: T23248), intramuscular in the left arm on 29Jan2021 at 10:00 AM as a single dose for COVID-19 immunization. Medical history included known allergies to sulfa. The patient did not have COVID prior to vaccination, had no other vaccine in four weeks and was not pregnant at the time of vaccination. Concomitant medications included multivitamins, ibuprofen, and paracetamol (TYLENOL). The patient received the first dose of BNT162B2 on 10Jan2021. On 29Jan2021 at 07:00 PM, the patient experienced uncontrollable chills, stabbing pain all over, headaches, body shakes, nausea, sensitivity to smells, "motion", and tired. The patient was not COVID tested after vaccination. The patient received no treatment for the events. Outcome of the events was recovering.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Parosmia, Tremor
Clinical narrative: Uncontrollable chills; stabbing pain all over; headaches; body shakes; nausea; sensitivity to smells; motion; tired; This is a spontaneous report from a contactable healthcare professional. A 54-year-old female patient received the second dose of BNT162B2 (Pfizer-BIONTECH COVID-19 Vaccine; Lot number: T23248), intramuscular in the left arm on 29Jan2021 at 10:00 AM as a single dose for COVID-19 immunization. Medical history included known allergies to sulfa. The patient did not have COVID prior to vaccination, had no other vaccine in four weeks and was not pregnant at the time of vaccination. Concomitant medications included multivitamins, ibuprofen, and paracetamol (TYLENOL). The patient received the first dose of BNT162B2 on 10Jan2021. On 29Jan2021 at 07:00 PM, the patient experienced uncontrollable chills, stabbing pain all over, headaches, body shakes, nausea, sensitivity to smells, "motion", and tired. The patient was not COVID tested after vaccination. The patient received no treatment for the events. Outcome of the events was recovering.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: lot of pain went around muscle shoulder pain; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine), via an unspecified route of administration, first dose on Jan2021 at single dose for COVID-19 vaccination.  The patient's medical history and concomitant medications were not reported. The patient experienced a lot of pain went around muscle shoulder pain on Jan2021. Patient took a paracetamol (TYLENOL) and takes aspirin. Patient was asking if it will reduce efficacy of vaccine dose and indicated that she will take second dose. The outcome of the event was unknown.   Information about lot/batch has been requested.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Pain in arm; This is a spontaneous report from a contactable consumer (patient herself). A 72-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: 1284, expiration date was unknown), via an unspecified route of administration in the left arm on 07Jan2021 at 16:00 at a single dose for COVID-19 immunization. The facility where the most recent COVID-19 vaccine was administered was the hospital. The patient's medical history and concomitant medications were not reported. The patient had no allergies to medications, food, or other products. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Jan2021 at 16:00, the patient experienced pain in arm, which was still bad after more than 3 weeks. The patient assessed the event as non-serious. Therapeutic measures were taken as a result of pain in arm, which included paracetamol (TYLENOL) or ibuprofen (ADVIL). The patient was not recovered from the event.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Cold sweat, Fatigue, Hypersomnia
Clinical narrative: Fever; chills; cold sweats; extremely achy body to the point where it was difficult to lift myself out of bed; extremely achy body to the point where it was difficult to lift myself out of bed; I also had extreme fatigue; I slept for almost 20 hours straight, and slept through work without waking up to call out; This is a spontaneous report from a contactable other healthcare professional reporting for herself.  A 34-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1238), intramuscular from 28Jan2021 15:45 (03:45 PM), (at the age of 34-years-old) at single dose on left arm for COVID-19 immunization. Patient was not pregnant at time of vaccination. Medical history included bipolar 2 disorder (reported as "ipolar 2 disorder") and attention deficit hyperactivity disorder (ADHD). Patient has no allergies to medications, food and other products. Patient was not diagnosed with COVID-19 prior vaccination. Concomitant medications (other medications the patient received within 2 weeks of vaccination) included lamotrigine (100 mg), amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL; reported as "Adderall XR 15 mg") and quetiapine fumarate (50 mg).  Patient did not received any other vaccines within 4 weeks prior vaccination. Facility where the most recent COVID-19 vaccine was administered was reported as "Other". The patient received first dose of COVID-19 vaccine on 07Jan2021 01:00 PM (lot number: EH9899), intramuscular on the left arm. On 29Jan2021 02:00 AM, the patient experienced fever, chills, cold sweats, extremely achy body to the point where it was difficult to lift herself out of bed. The patient also had extreme fatigue. Patient slept for almost 20 hours straight, and slept through work without waking up to call out. No treatment was received for the events. The events were assessed as non-serious. Outcome of the events was recovered in 2021. Body temperature on 29Jan2021 with unknown results. Since the vaccination, the patient has not been tested for COVID-19
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Pain, Pyrexia
Clinical narrative: Fever; chills; cold sweats; extremely achy body to the point where it was difficult to lift myself out of bed; extremely achy body to the point where it was difficult to lift myself out of bed; I also had extreme fatigue; I slept for almost 20 hours straight, and slept through work without waking up to call out; This is a spontaneous report from a contactable other healthcare professional reporting for herself.  A 34-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1238), intramuscular from 28Jan2021 15:45 (03:45 PM), (at the age of 34-years-old) at single dose on left arm for COVID-19 immunization. Patient was not pregnant at time of vaccination. Medical history included bipolar 2 disorder (reported as "ipolar 2 disorder") and attention deficit hyperactivity disorder (ADHD). Patient has no allergies to medications, food and other products. Patient was not diagnosed with COVID-19 prior vaccination. Concomitant medications (other medications the patient received within 2 weeks of vaccination) included lamotrigine (100 mg), amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL; reported as "Adderall XR 15 mg") and quetiapine fumarate (50 mg).  Patient did not received any other vaccines within 4 weeks prior vaccination. Facility where the most recent COVID-19 vaccine was administered was reported as "Other". The patient received first dose of COVID-19 vaccine on 07Jan2021 01:00 PM (lot number: EH9899), intramuscular on the left arm. On 29Jan2021 02:00 AM, the patient experienced fever, chills, cold sweats, extremely achy body to the point where it was difficult to lift herself out of bed. The patient also had extreme fatigue. Patient slept for almost 20 hours straight, and slept through work without waking up to call out. No treatment was received for the events. The events were assessed as non-serious. Outcome of the events was recovered in 2021. Body temperature on 29Jan2021 with unknown results. Since the vaccination, the patient has not been tested for COVID-19
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Left arm soreness; This is a spontaneous report from a contactable nurse (reporting for herself). A 51-year-old female patient received her second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL8982), via an unspecified route of administration from 28Jan2021 14:45 to 28Jan2021 14:45 at SINGLE DOSE for covid-19 immunization. The patient's medical history included Environmental allergies: some trees and grass. Concomitant medication included bupropion hydrochloride (WELLBUTRIN), loratadine, pseudoephedrine sulfate (CLARITIN-D), montelukast sodium (SINGULAIR), diphenhydramine hydrochloride (BENADRYL), colecalciferol (VITAMIN D [COLECALCIFEROL]), all for unspecified indication. The previously took her first dose of bnt162b2 on 07Jan2021 (lot number: EL3248) on her left arm for covid-19 immunization. On 28Jan2021 at 17:30, the patient experienced Left arm soreness beginning a few hours after vaccine administration and lasting about another 24 hours. The outcome of the event was recovered on an unspecified date. The seriousness of the event was reported as non-serious. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 since the vaccination.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Pruritus, Urticaria
Clinical narrative: My face broke out in hives; My face broke out in hives/were itchy and hot/ itching; My face broke out in hives/were itchy and hot; This is a spontaneous report from a contactable consumer (patient). A 27-year-old female patient received second dose of  bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3247; expiry date: unknown) via an unspecified route of administration in the left arm, on 25Jan2021 at 09:00, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) in the left arm on 04Jan2021 for COVID-19 immunization. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the hospital. On Friday, 30Jan2021 at 11:00, the patient's face broke out in hives. They were itchy and hot, and it was sudden, over the course of 15 to 30 minutes after the itching, they appeared. The patient took cetirizine hydrochloride before bed and applied cooling balm. The hives were gone this morning. The events were considered non-serious. Outcome of the events was recovered. The patient has not been tested for COVID-19 since vaccination.
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Malaise, Nausea
Clinical narrative: Severe dizziness; Felt tired; off kilter; nausea; This is a spontaneous report from a contactable consumer (patient). A 79-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; batch/lot number and expiration date unknown), via an unspecified route of administration in the left arm on 28Jan2021 15:00 at a single dose for covid-19 immunization at a Administration facility. The patient's medical history and concomitant medications were not reported. The patient was not diagnosed with Covid-19 prior to vaccination. The patient has no allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced severe dizziness upon awaking the following day (29Jan2021), which lessened as the day wore on. The patient also felt tired and off kilter all day with nausea from midday to night. The patient has not been tested for COVID-19 since the vaccination. The events were not treated. The outcome of the events was recovered on an unspecified date.  Information on the lot/batch number has been requested.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy, Rash
Clinical narrative: rash on right breast; swollen and painful axillary lymph node; swollen and painful axillary lymph node; This is a spontaneous report from a contactable healthcare professional (patient). A 28-year-old non-pregnant female patient received her second dose of bnt162b2 (BNT162B2 reported as COVID-19 vaccine; lot number: ek5730; expiration date: unknown) at the vaccination age of 28-year-old via an unspecified route of administration in the right arm on 13Jan2021 10:00 at a single dose for covid-19 immunisation. The patient medical history was not reported. The patient diagnosed with COVID-19 prior to vaccination. The patient has no allergies to medications, food, or other products. Concomitant medication included duloxetine hydrochloride (CYMBALTA), ibuprofen (ADVIL) and birth control medication. The patient first dose of bnt162b2 (BNT162B2 reported as COVID-19 vaccine; lot number: ek5730) at the vaccination age of 28-year-old via an unspecified route of administration in the right arm on 13Jan2021 10:00 at a single dose for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received the most recent COVID-19 vaccine in a hospital. On 15Jan2021, the patient had rash on right breast, and swollen and painful axillary lymph node. The patient did not receive treatment for the adverse events. The events were non-serious, and the events resulted in doctor or other healthcare professional office/clinic visit. The patient has not been tested for COVID-19 since the vaccination. The outcome of the events was not recovered.
Sex: M
Vaccine: COVID19
Symptoms: Cough, Nasopharyngitis
Clinical narrative: cold; I have a little cough; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age (reported as 85, unit unknown) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: not reported), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported.  On an unspecified date, it was reported that the patient was asking if he can get the 2nd dose of vaccine if he "has a cold". The patient also reported that "I have a little cough and I want to know if it is alright for me to take my second shot, I was supposed to take it in the morning, I have a cough and I wanted to know if is it all right me to take my second shot. I have a cold is it alright to take my second shot." The outcome of the events was unknown.   Information on lot/ batch number has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: dizziness; This is a spontaneous report received from a contactable consumer (patient). A male patient of an unspecified age (reported as "72", unit not provided) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), intramuscular, on 30Jan2021, at single dose, for COVID-19 immunization. Medical history included vertigo (reported as "vertigo real bad"). Concomitant medication included an unspecified blood thinner. On 30Jan2021, almost right away, the patient experienced dizziness. The patient was unsure if his dizziness was from the vaccine or from his history of vertigo. The patient also reported that he is taking a blood thinner and was not aware he needed to let his vaccination provider know until after he got his dose. He asked if he should be concerned. The outcome of the event was unknown.  Information on the Lot/Batch number has been requested.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: Sore arm; body aches; This is a spontaneous report from a contactable consumer (patient). A 54-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL1283; expiry date: unknown) via an unspecified route of administration in the left arm, on 25Jan2021 at 15:15, at a single dose, for COVID-19 immunization. The patient had no relevant medical history. Concomitant medication was not reported. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the workplace clinic. On 26Jan2021, at 04:00 AM, the patient experienced sore arm and body aches. The events were considered non-serious. The patient did not receive therapy for the events. Outcome of the events was unknown. The patient has not been tested for COVID-19 since vaccination.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: some soreness in left arm; This is a spontaneous report from a contactable consumer (patient).  A 78-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: EL9261), via an unspecified route of administration on 25Jan2021 at 13:45 at a single dose on the left arm for COVID-19 immunization.  Medical history included high blood pressure and a-fib (atrial fibrillation) both from an unknown date and unknown if ongoing. Prior to vaccination, the patient has not been diagnosed with COVID-19. Concomitant medication included lisinopril (LISINOPRIL), amlodipine (AMLODIPINE), atenolol (ATENOLOL), apixaban (ELIQUIS). Since the vaccination, the patient has not been tested for COVID-19. It was reported that the patient experienced some soreness in left arm next day, 26Jan2021. The patient did not receive any treatment for the event. The outcome of the event was recovered. The event was reported as non-serious.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Rash papular, Rash pruritic, Throat irritation
Clinical narrative: diffuse pink rash with white bumps over back and abdomen, to a smaller degree on arms. Also pruritis on back abdomen arms and legs.; diffuse pink rash with white bumps over back and abdomen, to a smaller degree on arms. Also pruritis on back abdomen arms and legs.; Mild scratchy throat; This is a spontaneous report from a contactable nurse (patient). A 59-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot EL3249), via an unspecified route of administration on 29Jan2021 13:15 at single dose (right arm) for COVID-19 immunization. Medical history included occasional gastric reflux and allergies. The patient was not pregnant. Patient had unspecified concomitant medications which was received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 29Jan2021, at 20:00, the patient developed a diffuse pink rash with white bumps over back and abdomen, to a smaller degree on arms. Also, pruritis on back abdomen arms and legs and mild scratchy throat. The patient noticed these symptoms several hours after injection and was worse on day 2. There was no treatment for the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. Outcome of events was not recovered.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Cough
Clinical narrative: Cough; This is a spontaneous report from a consumer (patient).  A 94-year-old female (also the age at vaccination) patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot number not reported), via an unspecified route of administration in the right arm on 26Jan2021 12:00 PM at SINGLE DOSE for COVID-19 immunization. The patient is vaccinated at a public health department. The patient is not pregnant. No other vaccines in four weeks. No COVID prior to vaccination and not COVID tested post vaccination. Medical history included High blood pressure, High Cholesterol both from unknown and if ongoing. Concomitant medication included amlodipine and simvastatin (reported as other medications in two weeks). It was reported that the patient experienced cough on 27Jan2021 at 12:00 PM. No treatment was given. The outcome of the event was not recovered.   Information about Batch/Lot number has been requested
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Eye pain, Fatigue, Headache
Clinical narrative: body aches/body aches and especially the throbbing in head became much worse by midday/achy; slight throbbing in head/throbbing in head became much worse by midday; very tired; body chills and hot sweats on and off; body chills and hot sweats on and off; still lethargic and achy but improving; slept all day, and all night; eye pain which was triggered by light and eye movements; eye pain which was triggered by light and eye movements; This is a spontaneous report received from a contactable nurse (who is also the patient). A 46-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9262, expiry date: unknown), via an unspecified route of administration on the left arm, on 29Jan2021 11:15, at single dose, for COVID-19 immunization, at an urgent care center. There was no medical history. The patient has no known allergies. The patient did not have COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination. The patient was not pregnant at the time of vaccination. Concomitant medication included probiotics. Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1686, expiry date: unknown) received at age 46 years, via an unspecified route of administration on the left arm, on 08Jan2021 11:15, for COVID-19 immunization. On 30Jan2021 at 07:00, the patient experienced body aches and slight throbbing in head which became worse by midday; was very tired; returned to bed within 30 minutes and slept all day, and all night; had eye pain which was triggered by light and eye movements; body chills and hot sweats of and off. The patient reported that although she never had a fever according to her non contact forehead thermometer, she had body chills and hot sweats on and off. 48 hours later, she was still lethargic and achy but improving. Treatment for the events included ibuprofen 600 mg every 4-5 hours which helped but did not completely relieve the discomforts. The patient was recovering from the events.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Hypersomnia, Lethargy, Pain, Photophobia
Clinical narrative: body aches/body aches and especially the throbbing in head became much worse by midday/achy; slight throbbing in head/throbbing in head became much worse by midday; very tired; body chills and hot sweats on and off; body chills and hot sweats on and off; still lethargic and achy but improving; slept all day, and all night; eye pain which was triggered by light and eye movements; eye pain which was triggered by light and eye movements; This is a spontaneous report received from a contactable nurse (who is also the patient). A 46-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9262, expiry date: unknown), via an unspecified route of administration on the left arm, on 29Jan2021 11:15, at single dose, for COVID-19 immunization, at an urgent care center. There was no medical history. The patient has no known allergies. The patient did not have COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination. The patient was not pregnant at the time of vaccination. Concomitant medication included probiotics. Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1686, expiry date: unknown) received at age 46 years, via an unspecified route of administration on the left arm, on 08Jan2021 11:15, for COVID-19 immunization. On 30Jan2021 at 07:00, the patient experienced body aches and slight throbbing in head which became worse by midday; was very tired; returned to bed within 30 minutes and slept all day, and all night; had eye pain which was triggered by light and eye movements; body chills and hot sweats of and off. The patient reported that although she never had a fever according to her non contact forehead thermometer, she had body chills and hot sweats on and off. 48 hours later, she was still lethargic and achy but improving. Treatment for the events included ibuprofen 600 mg every 4-5 hours which helped but did not completely relieve the discomforts. The patient was recovering from the events.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Pyrexia, Vomiting
Clinical narrative: Extreme muscle aches; fever; chills; headache; vomiting; This is a spontaneous report from a contactable healthcare professional reporting for herself.  A 42-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular in the left arm on 29Jan2021 17:15 (at the age of 42-years-old) at single dose for COVID-19 immunization in the workplace clinic. Medical history included endometriosis, acid reflux, and history of blood clots. The patient had no known allergies. The patient was not pregnant. The patient did not have COVID prior to vaccination. Concomitant medication included methyldopa hydrochloride (ALDOMET [METHYLDOPA HYDROCHLORIDE]), omeprazole (PROTONIX [OMEPRAZOLE]), probiotics (PROBIOTICS), cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) and vitamins. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscularly in the left arm on 08Jan2021 at 06:15 PM (at the age of 42-years-old) for COVID-19 immunization. The patient did not receive other vaccines in four weeks. The patient experienced extreme muscle aches, fever, chills, headache, vomiting on 30Jan2021 at 11:00 AM. The patient did not receive treatment for the events. The patient was not tested for COVID post vaccination. The outcome of the events was recovered in Jan2021. Information on the Lot/Batch number has been requested.